Efficacy of Additional Corticosteroids After Dexamethasone Treatment for Moderate to Severe COVID-19: An Observational Study

Background Previous studies have demonstrated dexamethasone (DEX)'s efficacy for coronavirus disease 2019 (COVID-19). In contrast, patients with residual lung field shading and symptoms after DEX treatment have been observed, and the efficacy of additional corticosteroids (AC) is unknown. Objec...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuda, Yosuke, Mochizuki, Kaoru, Ijichi, Miharu, Homma, Tetsuya, Tanaka, Akihiko, Sagara, Hironori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Allergy/Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487281/
https://www.ncbi.nlm.nih.gov/pubmed/37692586
http://dx.doi.org/10.7759/cureus.43179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487281/
https://www.ncbi.nlm.nih.gov/pubmed/37692586
http://dx.doi.org/10.7759/cureus.43179

Ejemplares similares